1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TRADD CTRPv2 pan-cancer AAC -0.11 0.003
mRNA KDM5A CTRPv2 pan-cancer AAC 0.11 0.003
mRNA HRASLS CTRPv2 pan-cancer AAC 0.11 0.003
mRNA CLCN3 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA AKNA CTRPv2 pan-cancer AAC 0.14 0.003
mRNA SPAG4 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA CIAPIN1 CTRPv2 pan-cancer AAC -0.1 0.003
mRNA RP11-296A16.1 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA RAB26 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA PRDX6 CTRPv2 pan-cancer AAC -0.1 0.003
Download CSV